Tissue-specific expression of p73 C-terminal isoforms in mice

Cell Cycle

Volumn 11, Issue 23, 2012, Pages 4474-4483

  Grespi, Francesca ^a,b   Amelio, Ivano ^a,b   Tucci, Paola ^a,c   Annicchiarico Petruzzelli, Margherita ^d   Melino, Gerry ^a,b,d  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY OF CALABRIA   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

C terminal isoforms; Cancer; Development; P73; SAM domain

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA; CYTOTOXIC AGENT; ETOPOSIDE; PROTEIN P53; PROTEIN P73; RNA; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN MOTIF; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; SPLEEN CELL; STERILE ALPHA MOTIF; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

EID: 84870931309     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.22787     Document Type: Article

References (129)

1. Levine AJ, Tomasini R, McKeon FD, Mak TW, Melino G. The p53 family: guardians of maternal reproduction. Nat Rev Mol Cell Biol 2011; 12:259-65; PMID:21427767; http://dx.doi.org/10.1038/nrm3086.
2. Talos F, Abraham A, Vaseva AV, Holembowski L, Tsirka SE, Scheel A, et al. p73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis. Cell Death Differ 2010; 17:1816-29; PMID:21076477; http://dx.doi.org/10.1038/cdd.2010.131.
3. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000; 404:99-103; PMID:10716451; http://dx.doi.org/10.1038/35003607.
4. Kommagani R, Whitlatch A, Leonard MK, Kadakia MP. p73 is essential for vitamin D-mediated osteoblastic differentiation. Cell Death Differ 2010; 17:398-407; PMID:19779497; http://dx.doi.org/10.1038/cdd.2009.135.
5. Das SSK, Somasundaram K. Therapeutic potential of an adenovirus expressing p73 β, a p53 homologue, against human papilloma virus positive cervical cancer in vitro and in vivo. Cancer Biol Ther 2006; 5:210-7; PMID:16481734; http://dx.doi.org/10.4161/cbt.5.2.2402.
6. Müller M, Schleithoff ES, Stremmel W, Melino G, Krammer PH, Schilling T. One, two, three - p53, p63, p73 and chemosensitivity. Drug Resist Updat 2006; 9:288-306; PMID:17287142; http://dx.doi.org/10.1016/j.drup.2007.01. 001.
7. Graupner V, Alexander E, Overkamp T, Rothfuss O, De Laurenzi V, Gillissen BF, et al. Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level. Cell Death Differ 2011; 18:1130-9; PMID:21233848; http://dx.doi.org/10.1038/cdd.2010.179.
8. John K, Alla V, Meier C, Pützer BM. GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria. Cell Death Differ 2011; 18:874-86; PMID:21127500; http://dx.doi.org/10.1038/cdd.2010.153.
9. Jiang M, Chiu SY, Hsu W. SUMO-specific protease 2 in Mdm2-mediated regulation of p53. Cell Death Differ 2011; 18:1005-15; PMID:21183956; http://dx.doi.org/10.1038/cdd.2010.168.
10. Slatter TL, Ganesan P, Holzhauer C, Mehta R, Rubio C, Williams G, et al. p53-mediated apoptosis prevents the accumulation of progenitor B cells and B-cell tumors. Cell Death Differ 2010; 17:540-50; PMID:19779492; http://dx.doi.org/10.1038/cdd.2009.136.
11. Knoll S, Fürst K, Thomas S, Villanueva Baselga S, Stoll A, Schaefer S, et al. Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: a role for HBV-induced HCC. Cell Cycle 2011; 10:3554-65; PMID:22030623; http://dx.doi.org/10.4161/cc.10.20.17856.
12. Klanrit P, Flinterman MB, Odell EW, Melino G, Killick R, Norris JS, et al. Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptin. Cell Cycle 2008; 7:205-15; PMID:18256531; http://dx.doi.org/10.4161/cc.7.2.5361.
13. Ramadan S, Terrinoni A, Catani MV, Sayan AE, Knight RA, Mueller M, et al. p73 induces apoptosis by different mechanisms. Biochem Biophys Res Commun 2005; 331:713-7; PMID:15865927; http://dx.doi.org/10.1016/j.bbrc.2005.03.156.
14. Toh WH, Nam SY, Sabapathy K. An essential role for p73 in regulating mitotic cell death. Cell Death Differ 2010; 17:787-800; PMID:20010785; http://dx.doi.org/10.1038/cdd.2009.181.
15. Rufini A, Niklison-Chirou MV, Inoue S, Tomasini R, Harris IS, Marino A, et al. TAp73 depletion accelerates aging through metabolic dysregulation. Genes Dev 2012; 26:2009-14; PMID:22987635; http://dx.doi.org/10.1101/gad.197640.112.
16. Rastogi S, Rizwani W, Joshi B, Kunigal S, Chellappan SP. TNF-α response of vascular endothelial and vascular smooth muscle cells involve differential utilization of ASK1 kinase and p73. Cell Death Differ 2012; 19:274-83; PMID:21738216; http://dx.doi.org/10.1038/cdd.2011.93.
17. Lane DP, Verma C, Fang CC. The p53 inducing drug dosage may determine quiescence or senescence. Aging (Albany NY) 2010; 2:748; PMID:21068468.
18. Galluzzi L, Kepp O, Kroemer G. TP53 and MTOR crosstalk to regulate cellular senescence. Aging (Albany NY) 2010; 2:535-7; PMID:20876940.
19. Horikawa I, Fujita K, Harris CC. p53 governs telomere regulation feedback too, via TRF2. Aging (Albany NY) 2011; 3:26-32; PMID:21266744.
20. Dulic V. Be quiet and you'll keep young: does mTOR underlie p53 action in protecting against senescence by favoring quiescence? Aging (Albany NY) 2011; 3:3-4; PMID:21248373.
21. Hulbert AJ. Longevity, lipids and C. elegans. Aging (Albany NY) 2011; 3:81-2; PMID:21386134.
22. Darzynkiewicz Z. Another "Janus paradox" of p53: induction of cell senescence versus quiescence. Aging (Albany NY) 2010; 2:329-30; PMID:20603525.
23. Poyurovsky MV, Prives C. P53 and aging: A fresh look at an old paradigm. Aging (Albany NY) 2010; 2:380-2; PMID:20657036.
24. Oswald C, Stiewe T. In good times and bad: p73 in cancer. Cell Cycle 2008; 7:1726-31; PMID:18583938; http://dx.doi.org/10.4161/cc.7.12.6148.
25. Collavin L, Lunardi A, Del Sal G. p53-family proteins and their regulators: hubs and spokes in tumor suppression. Cell Death Differ 2010; 17:901-11; PMID:20379196; http://dx.doi.org/10.1038/cdd.2010.35.
26. Toh WH, Nam SY, Sabapathy K. An essential role for p73 in regulating mitotic cell death. Cell Death Differ 2010; 17:787-800; PMID:20010785; http://dx.doi. org/10.1038/cdd.2009.181.
27. Schuster A, Schilling T, De Laurenzi V, Koch AF, Seitz S, Staib F, et al. ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria. Cell Cycle 2010; 9:2629-39; PMID:20581467; http://dx.doi.org/10.4161/cc.9.13.12110.
28. Ravni A, Tissir F, Goffinet AM. DeltaNp73 transcription factors modulate cell survival and tumor development. Cell Cycle 2010; 9:1523-7; PMID:20372082; http://dx.doi.org/10.4161/cc.9.8.11291.
29. Spinnler C, Hedström E, Li H, de Lange J, Nikulenkov F, Teunisse AF, et al. Abrogation of Wip1 expression by RITA-activated p53 potentiates apoptosis induction via activation of ATM and inhibition of HdmX. Cell Death Differ 2011; 18:1736-45; PMID:21546907; http://dx.doi.org/10.1038/cdd.2011.45.
30. Trinh DL, Elwi AN, Kim SW. Direct interaction between p53 and Tid1 proteins affects p53 mitochondrial localization and apoptosis. Oncotarget 2010; 1:396-404; PMID:21311096.
31. Li H, Lakshmikanth T, Garofalo C, Enge M, Spinnler C, Anichini A, et al. Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2. Cell Cycle 2011; 10:3346-58; PMID:21941086; http://dx.doi.org/10.4161/cc.10.19.17630.
32. Bao W, Chen M, Zhao X, Kumar R, Spinnler C, Thullberg M, et al. PRIMA-1Met/APR-246 induces wild-type p53-dependent suppression of malignant melanoma tumor growth in 3D culture and in vivo. Cell Cycle 2011; 10:301-7; PMID:21239882; http://dx.doi.org/10.4161/cc.10.2.14538.
33. Gao W, Shen Z, Shang L, Wang X. Upregulation of human autophagy-initiation kinase ULK1 by tumor suppressor p53 contributes to DNA-damage-induced cell death. Cell Death Differ 2011; 18:1598-607; PMID:21475306; http://dx.doi.org/10.1038/cdd.2011.33.
34. Leontieva OV, Blagosklonny MV. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Aging (Albany NY) 2010; 2:924-35; PMID:21212465.
35. Ho CC, Hau PM, Marxer M, Poon RY. The requirement of p53 for maintaining chromosomal stability during tetraploidization. Oncotarget 2010; 1:583-95; PMID:21317454.
36. Koster R, Timmer-Bosscha H, Bischoff R, Gietema JA, de Jong S. Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway. Cell Death Dis 2011; 2:e148; PMID:21509038; http://dx.doi.org/10.1038/cddis. 2011.33.
37. Hölzel M, Burger K, Mühl B, Orban M, Kellner M, Eick D. The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: a double-edged sword. Oncotarget 2010; 1:43-7; PMID:21293052.
38. Aoubala M, Murray-Zmijewski F, Khoury MP, Fernandes K, Perrier S, Bernard H, et al. p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage. Cell Death Differ 2011; 18:248-58; PMID:20689555; http://dx.doi.org/10.1038/cdd.2010.91.
39. Madan E, Gogna R, Bhatt M, Pati U, Kuppusamy P, Mahdi AA. Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor. Oncotarget 2011; 2:948-57; PMID:22248668.
40. Muppani N, Nyman U, Joseph B. TAp73alpha protects small cell lung carcinoma cells from caspase-2 induced mitochondrial mediated apoptotic cell death. Oncotarget 2011; 2:1145-54; PMID:22201672.
41. Napoli M, Girardini JE, Piazza S, Del Sal G. Wiring the oncogenic circuitry: Pin1 unleashes mutant p53. Oncotarget 2011; 2:654-6; PMID:21926448.
42. Steelman LS, Martelli AM, Nicoletti F, McCubrey JA. Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicity. Oncotarget 2011; 2:109-12; PMID:21487160.
43. Sorscher SM, Hill AE, Belizaire R, Sorscher EJ. Spontaneous inactivating p53 mutations and the "selfish cell". Aging (Albany NY) 2011; 3:181; PMID:21389353.
44. Lane DP, Madhumalar A, Lee AP, Tay BH, Verma C, Brenner S, et al. Conservation of all three p53 family members and Mdm2 and Mdm4 in the cartilaginous fish. Cell Cycle 2011; 10:4272-9; PMID:22107961; http://dx.doi.org/10.4161/cc.10.24.18567.
45. Zawacka-Pankau J, Kostecka A, Sznarkowska A, Hedström E, Kawiak A. p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach? Cell Cycle 2010; 9:720-8; PMID:20160513; http://dx.doi.org/10.4161/cc.9.4.10668.
46. Tissir F, Goffinet AM. p73 and p63: Estranged relatives? Cell Cycle 2011; 10:1351; PMID:21460637; http://dx.doi.org/10.4161/cc.10.9.15383.
47. Sayan AE, D'Angelo B, Sayan BS, Tucci P, Cimini A, Cerù MP, et al. p73 and p63 regulate the expression of fibroblast growth factor receptor 3. Biochem Biophys Res Commun 2010; 394:824-8; PMID:20298673; http://dx.doi.org/10. 1016/j.bbrc.2010.03.084.
48. Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC, et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 2008; 22:2677-91; PMID:18805989; http://dx.doi.org/10.1101/gad.1695308.
49. Grob TJ, Novak U, Maisse C, Barcaroli D, Lüthi AU, Pirnia F, et al. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ 2001; 8:1213-23; PMID:11753569; http://dx.doi.org/10.1038/sj. cdd.4400962.
50. Slade N, Zaika AI, Erster S, Moll UM. DeltaNp73 stabilises TAp73 proteins but compromises their function due to inhibitory hetero-oligomer formation. Cell Death Differ 2004; 11:357-60; PMID:14685155; http://dx.doi.org/10.1038/sj. cdd.4401335.
51. Vernersson-Lindahl E, Mills AA. DeltaNp73beta puts the brakes on DNA repair. Genes Dev 2010; 24:517-20; PMID:20231313; http://dx.doi.org/10.1101/gad. 1914210.
52. Niikura Y, Ogi H, Kikuchi K, Kitagawa K. BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD). Cell Death Differ 2010; 17:1011-24; PMID:20057499; http://dx.doi.org/10.1038/cdd.2009.207.
53. Bantel H, Simon HU. DeltaNp73beta is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria. Cell Cycle 2010; 9:2710-1; PMID:20676032; http://dx.doi.org/10.4161/cc.9.14. 12592.
54. Hüttinger-Kirchhof N, Cam H, Griesmann H, Hofmann L, Beitzinger M, Stiewe T. The p53 family inhibitor DeltaNp73 interferes with multiple developmental programs. Cell Death Differ 2006; 13:174-7; PMID:16341031; http://dx.doi.org/10.1038/sj.cdd.4401809.
55. Tissir F, Ravni A, Achouri Y, Riethmacher D, Meyer G, Goffinet AM. DeltaNp73 regulates neuronal survival in vivo. Proc Natl Acad Sci USA 2009; 106:16871-6; PMID:19805388; http://dx.doi.org/10.1073/pnas.0903191106.
56. Wilhelm MT, Rufini A, Wetzel MK, Tsuchihara K, Inoue S, Tomasini R, et al. Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway. Genes Dev 2010; 24:549-60; PMID:20194434; http://dx.doi.org/10.1101/gad.1873910.
57. Kon N, Zhong J, Kobayashi Y, Li M, Szabolcs M, Ludwig T, et al. Roles of HAUSP-mediated p53 regulation in central nervous system development. Cell Death Differ 2011; 18:1366-75; PMID:21350561; http://dx.doi.org/10.1038/cdd.2011.12.
58. Holembowski L, Schulz R, Talos F, Scheel A, Wolff S, Dobbelstein M, et al. While p73 is essential, p63 is completely dispensable for the development of the central nervous system. Cell Cycle 2011; 10:680-9; PMID:21293190; http://dx.doi.org/10.4161/cc.10.4.14859.
59. Agostini M, Tucci P, Steinert JR, Shalom-Feuerstein R, Rouleau M, Aberdam D, et al. microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc Natl Acad Sci USA 2011; 108:21099-104; PMID:22160706; http://dx.doi.org/10.1073/pnas.1112063108.
60. Agostini M, Tucci P, Killick R, Candi E, Sayan BS, Rivetti di Val Cervo P, et al. Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc Natl Acad Sci USA 2011; 108:21093-8; PMID:22160687; http://dx.doi.org/10.1073/pnas.1112061109.
61. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997; 90:809-19; PMID:9288759; http://dx.doi.org/10.1016/S0092-8674(00)80540-1.
62. Chi SW, Ayed A, Arrowsmith CH. Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain. EMBO J 1999; 18:4438-45; PMID:10449409; http://dx.doi.org/10.1093/emboj/18.16.4438.
63. Thanos CD, Bowie JU. p53 Family members p63 and p73 are SAM domain-containing proteins. Protein Sci 1999; 8:1708-10; PMID:10452616; http://dx.doi.org/10.1110/ps.8.8.1708.
64. Arrowsmith CH. Structure and function in the p53 family. Cell Death Differ 1999; 6:1169-73; PMID:10637432; http://dx.doi.org/10.1038/sj.cdd.4400619.
65. De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, Annicchiarico-Petruzzelli M, et al. Two new p73 splice variants, gamma and delta, with different transcriptional activity. J Exp Med 1998; 188:1763-8; PMID:9802988; http://dx.doi.org/10.1084/jem.188.9.1763.
66. De Laurenzi VD, Catani MV, Terrinoni A, Corazzari M, Melino G, Costanzo A, et al. Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta. Cell Death Differ 1999; 6:389-90; PMID:10381648; http://dx.doi.org/10.1038/sj.cdd.4400521.
67. Coutandin D, Löhr F, Niesen FH, Ikeya T, Weber TA, Schäfer B, et al. Conformational stability and activity of p73 require a second helix in the tetramerization domain. Cell Death Differ 2009; 16:1582-9; PMID:19763140; http://dx.doi.org/10.1038/cdd.2009.139.
68. Rosenbluth JM, Johnson K, Tang L, Triplett T, Pietenpol JA. Evaluation of p63 and p73 antibodies for cross-reactivity. Cell Cycle 2009; 8:3702-6; PMID:19855172; http://dx.doi.org/10.4161/cc.8.22.10036.
69. Sayan AE, Paradisi A, Vojtesek B, Knight RA, Melino G, Candi E. New antibodies recognizing p73: comparison with commercial antibodies. Biochem Biophys Res Commun 2005; 330:186-93; PMID:15781249; http://dx.doi.org/10.1016/j. bbrc.2005.02.145.
70. Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin WG Jr., Levrero M, et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 1999; 399:806-9; PMID:10391249; http://dx.doi.org/10.1038/21690.
71. De Laurenzi V, Raschellá G, Barcaroli D, Annicchiarico-Petruzzelli M, Ranalli M, Catani MV, et al. Induction of neuronal differentiation by p73 in a neuroblastoma cell line. J Biol Chem 2000; 275:15226-31; PMID:10809758; http://dx.doi.org/10.1074/jbc.275.20.15226.
72. Conforti F, Sayan AE, Sreekumar R, Sayan BS. Regulation of p73 activity by post-translational modifications. Cell Death Dis 2012; 3:e285; PMID:22419114; http://dx.doi.org/10.1038/cddis.2012.27.
73. Gonzalez-Cano L, Herreros-Villanueva M, Fernandez-Alonso R, Ayuso-Sacido A, Meyer G, Garcia-Verdugo JM, et al. p73 deficiency results in impaired self renewal and premature neuronal differentiation of mouse neural progenitors independently of p53. Cell Death Dis 2010; 1:e109; PMID:21368881; http://dx.doi.org/10.1038/cddis.2010.87.
74. Saifudeen Z, Diavolitsis V, Stefkova J, Dipp S, Fan H, El-Dahr SS. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression. J Biol Chem 2005; 280:23094-102; PMID:15805112; http://dx.doi.org/10.1074/jbc.M414575200.
75. Dötsch FB, Coutandin D, Candi E, Melino G. p63 and p73, the Ancestors of p53. Cold Spring Harb Perspect Biol 2010; 00:a004887.
76. Wang X, Zeng L, Wang J, Chau JF, Lai KP, Jia D, et al. A positive role for c-Abl in Atm and Atr activation in DNA damage response. Cell Death Differ 2011; 18:5-15; PMID:20798688; http://dx.doi.org/10.1038/cdd.2010.106.
77. Toh WH, Siddique MM, Boominathan L, Lin KW, Sabapathy K. c-Jun regulates the stability and activity of the p53 homologue, p73. J Biol Chem 2004; 279:44713-22; PMID:15302867; http://dx.doi.org/10.1074/jbc.M407672200.
78. Seviour EG, Lin SY. The DNA damage response: Balancing the scale between cancer and ageing. Aging (Albany NY) 2010; 2:900-7; PMID:21191148.
79. Prendergast AM, Cruet-Hennequart S, Shaw G, Barry FP, Carty MP. Activation of DNA damage response pathways in human mesenchymal stem cells exposed to cisplatin or γ-irradiation. Cell Cycle 2011; 10:3768-77; PMID:22037398; http://dx.doi.org/10.4161/cc.10.21.17972.
80. Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, et al. Molecular mechanisms of cisplatin resistance. Oncogene 2012; 31:1869-83; PMID:21892204; http://dx.doi.org/10.1038/onc.2011.384.
81. De Zio D, Bordi M, Tino E, Lanzuolo C, Ferraro E, Mora E, et al. The DNA repair complex Ku70/86 modulates Apaf1 expression upon DNA damage. Cell Death Differ 2011; 18:516-27; PMID:20966962; http://dx.doi.org/10.1038/cdd.2010.125.
82. Zalckvar E, Yosef N, Reef S, Ber Y, Rubinstein AD, Mor I, et al. A systems level strategy for analyzing the cell death network: implication in exploring the apoptosis/autophagy connection. Cell Death Differ 2010; 17:1244-53; PMID:20150916; http://dx.doi.org/10.1038/cdd.2010.7.
83. Bialik S, Zalckvar E, Ber Y, Rubinstein AD, Kimchi A. Systems biology analysis of programmed cell death. Trends Biochem Sci 2010; 35:556-64; PMID:20537543; http://dx.doi.org/10.1016/j.tibs.2010.04.008.
84. Meley D, Spiller DG, White MR, McDowell H, Pizer B, Sée V. p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma. Cell Death Dis 2010; 1:e41; PMID:21364648; http://dx.doi.org/10.1038/cddis.2010.16.
85. Zhang H, Li Y, Huang Q, Ren X, Hu H, Sheng H, et al. MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Differ 2011; 18:1702-10; PMID:21455217; http://dx.doi.org/10.1038/cdd.2011.28.
86. Boehler C, Dantzer F. PARP-3, a DNA-dependent PARP with emerging roles in double-strand break repair and mitotic progression. Cell Cycle 2011; 10:1023-4; PMID:21358266; http://dx.doi.org/10.4161/cc.10.7.15169.
87. Straten P, Andersen MH. The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens. Oncotarget 2010; 1:239-45; PMID:21304176.
88. van Vuurden DG, Hulleman E, Meijer OL, Wedekind LE, Kool M, Witt H, et al. PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation. Oncotarget 2011; 2:984-96; PMID:22184287.
89. Cantó C, Auwerx J. Interference between PARPs and SIRT1: a novel approach to healthy ageing? Aging (Albany NY) 2011; 3:543-7; PMID:21566260.
90. Schultz J, Ponting CP, Hofmann K, Bork P. SAM as a protein interaction domain involved in developmental regulation. Protein Sci 1997; 6:249-53; PMID:9007998; http://dx.doi.org/10.1002/pro.5560060128.
91. Liu G, Chen X. The C-terminal sterile alpha motif and the extreme C terminus regulate the transcriptional activity of the alpha isoform of p73. J Biol Chem 2005; 280:20111-9; PMID:15769743; http://dx.doi. org/10.1074/jbc. M413889200.
92. Ozaki T, Naka M, Takada N, Tada M, Sakiyama S, Nakagawara A. Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells. Cancer Res 1999; 59:5902-7; PMID:10606232.
93. Deutsch GB, Zielonka EM, Coutandin D, Weber TA, Schäfer B, Hannewald J, et al. DNA damage in oocytes induces a switch of the quality control factor TAp63α from dimer to tetramer. Cell 2011; 144:566-76; PMID:21335238; http://dx.doi.org/10.1016/j.cell.2011.01.013.
94. Melino G. p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell Death Differ 2011; 18:1487-99; PMID:21760596; http://dx.doi.org/10.1038/cdd.2011.81.
95. Yalcin-Ozuysal O, Fiche M, Guitierrez M, Wagner KU, Raffoul W, Brisken C. Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates. Cell Death Differ 2010; 17:1600-12; PMID:20379195; http://dx.doi.org/10. 1038/cdd.2010.37.
96. Huang Y, Ratovitski EA. Phospho-ΔNp63α/Rpn13-dependent regulation of LKB1 degradation modulates autophagy in cancer cells. Aging (Albany NY) 2010; 2:959-68; PMID:21191146.
97. Straub WE, Weber TA, Schäfer B, Candi E, Durst F, Ou HD, et al. The C-terminus of p63 contains multiple regulatory elements with different functions. Cell Death Dis 2010; 1:e5; PMID:21364624; http://dx.doi.org/10.1038/ cddis.2009.1.
98. Neilsen PM, Noll JE, Suetani RJ, Schulz RB, Al-Ejeh F, Evdokiou A, et al. Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome. Oncotarget 2011; 2:1203-17; PMID:22203497.
99. Lena AM, Cipollone R, Amelio I, Catani MV, Ramadan S, Browne G, et al. Skn-1a/Oct-11 and ΔNp63αexert antagonizing effects on human keratin expression. Biochem Biophys Res Commun 2010; 401:568-73; PMID:20888799; http://dx.doi.org/10.1016/j.bbrc.2010.09.102.
100. Ghioni P, Bolognese F, Duijf PH, Van Bokhoven H, Mantovani R, Guerrini L. Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains. Mol Cell Biol 2002; 22:8659-68; PMID:12446784; http://dx.doi.org/10.1128/MCB.22.24.8659-8668.2002.
101. Shalom-Feuerstein R, Lena AM, Zhou H, De La Forest Divonne S, Van Bokhoven H, Candi E, et al. ΔNp63 is an ectodermal gatekeeper of epidermal morphogenesis. Cell Death Differ 2011; 18:887-96; PMID:21127502; http://dx.doi.org/10.1038/cdd.2010.159.
102. Borrelli S, Candi E, Hu B, Dolfini D, Ravo M, Grober OM, et al. The p63 target HBP1 is required for skin differentiation and stratification. Cell Death Differ 2010; 17:1896-907; PMID:20523354; http://dx.doi.org/10.1038/cdd.2010.59.
103. Talos F, Wolff S, Beyer U, Dobbelstein M, Moll UM. Brdm2 - an aberrant hypomorphic p63 allele. Cell Death Differ 2010; 17:184-6; PMID:20161489; http://dx.doi.org/10.1038/cdd.2009.158.
104. Leonard MK, Kommagani R, Payal V, Mayo LD, Shamma HN, Kadakia MP. ΔNp63α regulates keratinocyte proliferation by controlling PTEN expression and localization. Cell Death Differ 2011; 18:1924-33; PMID:21637289; http://dx.doi.org/10.1038/cdd.2011.73.
105. van Bokhoven H, Hamel BC, Bamshad M, Sangiorgi E, Gurrieri F, Duijf PH, et al. p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am J Hum Genet 2001; 69:481-92; PMID:11462173; http://dx.doi.org/10.1086/323123.
106. Forster N, Ellisen LW. Notch signaling mediates p63-induced quiescence: a new facet of p63/Notch crosstalk. Cell Cycle 2011; 10:3632-3; PMID:22041817; http://dx.doi.org/10.4161/cc.10.21.18182.
107. Kim DA, Lee BL, Suh EK. Ionizing radiation-induced TAp63α phosphorylation at C-terminal S/TQ motifs requires the N-terminal transactivation (TA) domain. Cell Cycle 2011; 10:840-9; PMID:21325887; http://dx.doi.org/10.4161/cc.10.5.15008.
108. Lee J, Hwang YJ, Boo JH, Han D, Kwon OK, Todorova K, et al. Dysregulation of upstream binding factor-1 acetylation at K352 is linked to impaired ribosomal DNA transcription in Huntington's disease. Cell Death Differ 2011; 18:1726-35; PMID:21546905; http://dx.doi.org/10.1038/cdd.2011.38.
109. Penas C, Font-Nieves M, Forés J, Petegnief V, Planas A, Navarro X, et al. Autophagy, and BiP level decrease are early key events in retrograde degeneration of motoneurons. Cell Death Differ 2011; 18:1617-27; PMID:21436843; http://dx.doi.org/10.1038/cdd.2011.24.
110. Rass U, Ahel I, West SC. Defective DNA repair and neurodegenerative disease. Cell 2007; 130:991-1004; PMID:17889645; http://dx.doi.org/10.1016/j. cell.2007.08.043.
111. Nisoli I, Chauvin JP, Napoletano F, Calamita P, Zanin V, Fanto M, et al. Neurodegeneration by polyglutamine Atrophin is not rescued by induction of autophagy. Cell Death Differ 2010; 17:1577-87; PMID:20339376; http://dx.doi.org/10.1038/cdd.2010.31.
112. Ciavardelli D, Silvestri E, Del Viscovo A, Bomba M, De Gregorio D, Moreno M, et al. Alterations of brain and cerebellar proteomes linked to Aβ and tau pathology in a female triple-transgenic murine model of Alzheimer's disease. Cell Death Dis 2010; 1:e90; PMID:21368863; http://dx.doi.org/10.1038/ cddis.2010.68.
113. Stanga S, Lanni C, Govoni S, Uberti D, D'Orazi G, Racchi M. Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link? Aging (Albany NY) 2010; 2:545-54; PMID:20876941.
114. Olsson M, Zhivotovsky B. Caspases and cancer. Cell Death Differ 2011; 18:1441-9; PMID:21455218; http://dx.doi.org/10.1038/cdd.2011.30.
115. Kelly PN, Strasser A. The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ 2011; 18:1414-24; PMID:21415859; http://dx.doi.org/10.1038/cdd.2011.17.
116. Ahmed A, Yang J, Maya-Mendoza A, Jackson DA, Ashcroft M. Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1. Cell Death Dis 2011; 2:e160; PMID:21593792; http://dx.doi.org/10.1038/cddis.2011.42.
117. Smit MA, Peeper DS. Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths. Aging (Albany NY) 2010; 2:735-41; PMID:20975209.
118. Lu WJ, Lee NP, Kaul SC, Lan F, Poon RT, Wadhwa R, et al. Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy. Cell Death Differ 2011; 18:1046-56; PMID:21233847; http://dx.doi.org/10.1038/cdd.2010.177.
119. Mallette FA, Calabrese V, Ilangumaran S, Ferbeyre G. SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence. Aging (Albany NY) 2010; 2:445-52; PMID:20622265.
120. Agostini M, Tucci P, Melino G. Cell death pathology: perspective for human diseases. Biochem Biophys Res Commun 2011; 414:451-5; PMID:21964290; http://dx.doi.org/10.1016/j.bbrc.2011.09.081.
121. Rufini A, Agostini M, Grespi F, Tomasini R, Sayan BS, Niklison-Chirou MV, et al. p73 in Cancer. Genes Cancer 2011; 2:491-502; PMID:21779517; http://dx.doi.org/10.1177/1947601911408890.
122. Rufini S, Lena AM, Cadot B, Mele S, Amelio I, Terrinoni A, et al. The sterile alpha-motif (SAM) domain of p63 binds in vitro monoasialoganglioside (GM1) micelles. Biochem Pharmacol 2011; 82:1262-8; PMID:21820419; http://dx.doi.org/10.1016/j.bcp.2011.07.087.
123. Barrera FN, Poveda JA, González-Ros JM, Neira JL. Binding of the C-terminal sterile alpha motif (SAM) domain of human p73 to lipid membranes. J Biol Chem 2003; 278:46878-85; PMID:12954612; http://dx.doi.org/10.1074/jbc. M307846200.
124. Drakas R, Prisco M, Baserga R. A modified tandem affinity purification tag technique for the purification of protein complexes in mammalian cells. Proteomics 2005; 5:132-7; PMID:15602769; http://dx.doi.org/10.1002/pmic. 200400919.
125. Knuesel M, Wan Y, Xiao Z, Holinger E, Lowe N, Wang W, et al. Identification of novel protein-protein interactions using a versatile mammalian tandem affinity purification expression system. Mol Cell Proteomics 2003; 2:1225-33; PMID:12963786; http://dx.doi.org/10.1074/mcp.T300007-MCP200.
126. Eyckerman S, Lemmens I, Lievens S, Van der Heyden J, Verhee A, Vandekerckhove J, et al. Design and use of a mammalian protein-protein interaction trap (MAPPIT). Sci STKE 2002; 2002:pl18; PMID:12476003; http://dx.doi.org/10.1126/stke.2002.162.pl18.
127. Tavernier J, Eyckerman S, Lemmens I, Van der Heyden J, Vandekerckhove J, Van Ostade X. MAPPIT: a cytokine receptor-based two-hybrid method in mammalian cells. Clin Exp Allergy 2002; 32:1397-404; PMID:12372116; http://dx.doi.org/10. 1046/j.1365-2745.2002.01520.x.
128. Grespi F, Ottina E, Yannoutsos N, Geley S, Villunger A. Generation and evaluation of an IPTG-regulated version of Vav-gene promoter for mouse transgenesis. PLoS One 2011; 6:e18051; PMID:21445314; http://dx.doi.org/10.1371/ journal.pone.0018051.
129. Amelio I, Lena AM, Viticchiè G, Shalom-Feuerstein R, Terrinoni A, Dinsdale D, et al. miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migration. J Cell Biol 2012; 199:347-63; PMID:23071155; http://dx.doi.org/10.1083/jcb.201203134.